Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-011988
Filing Date
2022-03-28
Accepted
2022-03-28 16:31:03
Documents
7
Period of Report
2022-03-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A pstv-pre14a_20220328.htm PRE 14A 1218547
2 GRAPHIC g3ciuwra3ars000005.jpg GRAPHIC 11795
3 GRAPHIC g3ciuwra3ars000004.jpg GRAPHIC 11795
4 GRAPHIC g3ciuwra3ars000006.jpg GRAPHIC 768834
5 GRAPHIC g3ciuwra3ars000001.jpg GRAPHIC 49190
6 GRAPHIC g3ciuwra3ars000002.jpg GRAPHIC 11795
7 GRAPHIC g3ciuwra3ars000007.jpg GRAPHIC 470905
  Complete submission text file 0001564590-22-011988.txt   3040110
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 22775832
SIC: 3841 Surgical & Medical Instruments & Apparatus